Dermalax Implant Plus
$48.50
Dermalax Implant Plus is a premium high-density hyaluronic acid filler (24mg/ml HA + 0.3% lidocaine) developed by Hugel Pharma using EU/KFDA-certified manufacturing processes. Featuring ultra-low BDDE ≤2ppm and optimal G’ elasticity (450-550Pa), it provides precise volumization for severe wrinkles, jawline/cheek contouring, and non-surgical rhinoplasty. Clinically proven with 89% patient satisfaction and endotoxin levels <0.05 EU/ml, this advanced dermal volumizer delivers natural results with enhanced safety through RFID-tracked sterile packaging.
| Mix-And-Match Quantity | Get More Discount | Final Price |
|---|---|---|
| 5-15 | 4% | $46.56 |
| 16-30 | 6% | $45.59 |
| 31-Unlimited | 8% | $44.62 |
Dermalax Implant Plus
Premium High-Density HA Filler with Integrated Lidocaine
Advanced Dermal Volumizer
Dermalax Implant Plus is a high-density hyaluronic acid dermal filler (24mg/ml HA + 0.3% lidocaine) designed for deep structural augmentation. With superior viscoelastic properties (G’ 450-550Pa) and ultra-low BDDE ≤2ppm, it enables precise volumization of NLF2-3 wrinkles, jawline contouring and non-surgical rhinoplasty. Clinically proven with 89% patient satisfaction at 6 months and duration up to 12 months. Manufactured under strict EU/KFDA standards with endotoxin levels <0.05 EU/ml.
Key Advantages
Ultra-Pure Formulation
≤2ppm BDDE content with 99.9% pure HA and endotoxin levels <0.05 EU/ml for enhanced biocompatibility
Integrated Anesthesia
0.3% lidocaine formula ensures pain-free application during facial volumization procedures
High Precision G’ Value
Optimal 450-550Pa elasticity provides superior tissue support and natural distribution
Technical Specifications
Core Technology
- Low-temperature stabilization technology
- Cross-linked HA molecules (24mg/ml)
- Residual BDDE ≤2ppm
Indications
- Severe nasolabial folds (NLF2-3)
- Jawline/cheek contouring
- Non-surgical rhinoplasty
- Temporal hollow correction
Packaging Specifications
Sterility
EO sterilized, single-use only
Storage
2-25°C protected from light, do not freeze
Traceability
Full RFID batch tracking
Clinical Administration Protocol
Implantation Depth
Deep dermal/subcutaneous only
Max Dosage
≤2.2ml per treatment area
Aspiration
Mandatory before injection
Medical Safety Notice
Individual results vary based on injection technique and patient physiology. This prescription medical device must be administered by licensed practitioners only. Hugel Pharma assumes no liability for complications arising from off-label use or unqualified administration. Report adverse events to local regulatory authorities.

Reviews
There are no reviews yet.